Professor Elizabeth Hartland appointed AAMRI President Elect

Hudson Institute’s Director and CEO, Professor Elizabeth Hartland, has been appointed the President Elect for the Association of Australian Medical Research Institutes (AAMRI).

Professor Elizabeth Hartland
Institute Director and CEO, Professor Elizabeth Hartland

Professor Hartland will advance from her current roles as a member of the Board and the Chair of the Victorian branch of AAMRI, to take on the national leadership as President in 2023.

“Being part of the board for the past five years has been a great opportunity to work on behalf of the medical research institutes we represent. Now, moving to the role of President late next year I’m looking forward to continuing AAMRI’s work to ensure the long-term future of our workforce and the sector,” said Professor Hartland.

International science leader

Prof Hartland is an international leader in the field of microbiology and immunology who brings a wealth of experience to the role beyond her specialty area of microbial drug resistance.

She has held a Royal Society/NHMRC Howard Florey Fellowship in the Department of Biochemistry, Imperial College London and Lecturer/Senior Lecturer positions at Monash University.

As well as her role at Hudson Institute, which she has held since 2017, Prof Hartland is Head of the Department of Molecular and Translational Science at Monash University.

Before joining Hudson Institute, Professor Hartland held the positions of Head of the Department of Microbiology and Immunology, University of Melbourne and Deputy Director of the Doherty Institute for Infection and Immunity.

Professor Kathryn North AC, current AAMRI President, will work closely with Professor Hartland over the next year until November 2023 when Professor North will step down, and Professor Hartland’s appointment will begin.

“Professor Hartland is ideal for the position, and I was thrilled when she accepted the role. She has excellent knowledge of our sector, its policies, funding bodies and researchers and the challenges and opportunities coming up for medical research institutes,” said Professor North.

Contact us

Hudson Institute communications
t: + 61 3 8572 2761